Radiopharm Theranostics Limited (AU:RAD) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Radiopharm Theranostics Limited announced the cessation of 13,680,012 restricted options that expired on November 25, 2024, without exercise or conversion. This development may interest investors watching the company’s capital management strategies and stock performance. Keep an eye on how this could influence Radiopharm’s market dynamics.
For further insights into AU:RAD stock, check out TipRanks’ Stock Analysis page.